Sandbox:Roukoz: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 66: | Line 66: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Lump that has been rapidly growing over the past weeks | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 74: | Line 75: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Cells proliferate downwards through the skin (vertical growth) | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Skin biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Two-thirds arise in normal skin, the rest in existing moles | * Two-thirds arise in normal skin, the rest in existing moles | ||
Line 114: | Line 114: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Skin biopsy | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
|- | |- | ||
Line 191: | Line 191: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Yellow-nodule | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 201: | Line 202: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Suspected due to evidence of eyelash loss | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Rhabdomyosarcoma''' | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Bulging of the eye or a swollen eyelid | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 220: | Line 219: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Develops in skeletal muscles usually | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratoses''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Actinic keratoses''' | ||
Line 259: | Line 259: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Eczema-like rash of the skin | |||
| style="background: #F5F5F5; padding: 5px;" |Around the genital regions of males and females. | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 266: | Line 268: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Similar to mammary paget disease | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |chronic | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Inflamed seborrheic keratosis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Inflamed seborrheic keratosis''' | ||
Line 361: | Line 361: | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Psoriasis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Psoriasis''' | ||
| style="background: #F5F5F5; padding: 5px;" |Flaking, inflammation | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Thick, white, silvery, or red patches of skin | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 373: | Line 375: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Chronic condition | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pyoderma gangrenosum''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Pyoderma gangrenosum''' | ||
Line 432: | Line 432: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Red scaly patch | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 442: | Line 443: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Very early form of skin cancer that is very treatable | ||
referred to as squamous cell carcinoma insitu | |||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous Hyperplasia''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''Sebaceous Hyperplasia''' | ||
Line 449: | Line 450: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" |Lesions can be single or multiple lesions | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | Yellowish, soft, small papules on the face | ||
| style="background: #F5F5F5; padding: 5px;" |Usually on the nose, cheeks, and forehead | |||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
Line 580: | Line 583: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" |Rare autosomal-dominant disorder of the conjunctiva and oral mucosa | ||
|- | |- | ||
| style="background: #DCDCDC; padding: 5px; text-align: center;" |'''primary acquired melanosis''' | | style="background: #DCDCDC; padding: 5px; text-align: center;" |'''primary acquired melanosis''' |
Revision as of 20:40, 31 January 2019
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||
Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | ||||
Cutaneous squamous cell carcinoma | pain | erythema | indurated | hyperkeratotic | increased size | skin biopsy |
| ||||||||
Merkel cell carcinoma | Starts on areas of skin exposed to the sun | Single pink, red, or purple shiny bump | Painless | Skin biopsy | blue-red, dome-shaped nodule | ||||||||||
Nodular malignant melanoma | Lump that has been rapidly growing over the past weeks | Cells proliferate downwards through the skin (vertical growth) | Skin biopsy |
| |||||||||||
Amelanotic melanoma | Color usually pink, purple or normal skin color | Usually have an asymmetrical shape with an irregular border | red, nonspecific lesion with slightly elevated borders | skin biopsy |
| ||||||||||
Basal cell carcinoma | Coarse scale lesion | Skin biopsy | |||||||||||||
Superficial basal cell carcinoma | scaly patch | erythematous lesion |
|
skin biopsy | |||||||||||
Nodular basal cell carcinoma | Pearly papule with telangiectasias | Skin biopsy | |||||||||||||
Cutaneous metastases of internal malignancy | |||||||||||||||
Benign Skin Lesions | |||||||||||||||
Sebaceous cell carcinoma | Yellow-nodule | Suspected due to evidence of eyelash loss | |||||||||||||
Rhabdomyosarcoma | Bulging of the eye or a swollen eyelid | Develops in skeletal muscles usually | |||||||||||||
Actinic keratoses | pain | hyperkeratosis | erythema | less pigmentation, and tend to be somewhat smaller in size. | Skin biopsy | ||||||||||
Prurigo nodules | Hard lesion | Itchy lumps | |||||||||||||
Paget disease | Eczema-like rash of the skin | Around the genital regions of males and females. | Similar to mammary paget disease | chronic | |||||||||||
Inflamed seborrheic keratosis | waxy, "stuck on," often hyperkeratotic appearance | On dermatoscopic evaluation, presence of horned cysts and hairpin-shaped blood vessels | Skin biopsy | ||||||||||||
Viral warts | Verrucous lesion | Caused by HPV | |||||||||||||
Pyogenic granuloma | Rapidly growing | Red, dome-shaped | Friable papule with a collarette of scale | ||||||||||||
Bowenoid papulosis | multiple, red- to brown-colored, small papules that |
| |||||||||||||
Nummular eczema | Itchy lesions | Coin shaped spots | Chronic condition | ||||||||||||
Psoriasis | Flaking, inflammation | Thick, white, silvery, or red patches of skin | Chronic condition | ||||||||||||
Pyoderma gangrenosum | Purulent ulcer | Ragged and violaceous border | |||||||||||||
Venous stasis ulcers | |||||||||||||||
Traumatic ulcers | |||||||||||||||
Bowen Disease | Red scaly patch | Very early form of skin cancer that is very treatable
referred to as squamous cell carcinoma insitu | |||||||||||||
Sebaceous Hyperplasia | Lesions can be single or multiple lesions |
Yellowish, soft, small papules on the face |
Usually on the nose, cheeks, and forehead | ||||||||||||
Allergic Contact Dermatitis | Itchy rash | Red rash | Not contagious | ||||||||||||
Atopic Dermatitis | Itchy rash | Fever | Red rash | Chronic and sometimes accompanied by asthma | |||||||||||
Atypical Fibroxanthoma | Erythematous, dome-shaped papule | ||||||||||||||
Nevus | |||||||||||||||
Chemical Burns | |||||||||||||||
Limbal Dermoid | Contains choristomatous tissue | Benign congenital tumor | |||||||||||||
Benign hereditary intraepithelial dyskeratosis | Rare autosomal-dominant disorder of the conjunctiva and oral mucosa | ||||||||||||||
primary acquired melanosis | |||||||||||||||
Fibrous xanthoma | Containing fibromatous elements | Arises due to disturbed systemic lipid metabolism | |||||||||||||
Inflamed seborrheic keratosis | Inflamed and hyperpigmented | ||||||||||||||
Juvenile xanthogranuloma | Reddened, yellowish-tan color of lesions | Slightly raised bumps | Typically |